Spiriva® Respimat®

DEVICE2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Unknown Phase

Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy

CompletedNCT02173769

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2014-06-30End: 2015-03-31Updated: 2017-06-05

Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drug

TerminatedNCT05362487

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2022-08-05End: 2023-01-18Updated: 2025-02-26